Urge your Senators TODAY to co-sponsor a $50 million budget — a $5 million funding increase over current levels — for the federal Ovarian Cancer Research Program! This April, we asked for our community’s help in collecting signatures on a bipartisan Dear Colleague letter in the House of Representatives requesting a major funding increase to the Ovarian … Continued
Mother’s Day signifies so much to so many—celebration, gratitude, and yes, remembrance or loss. This year, we want to acknowledge just some of our many supporters who have taken their love for their moms and transformed it into a gift for our entire community. Whether biking across the country or putting on a virtual play, … Continued
The interaction between two partner proteins may promote the growth of the most common ovarian cancer subtype, according to recent findings from OCRA-funded researchers at University of Pennsylvania and Cedars-Sinai Medical Center and their colleagues. The learnings, which were published in Science Signaling, may pave the way for the future development of new targeted therapies. HGSOC … Continued
A therapeutic strategy that targets key tumor proteins shows promise for treating the most common subtype of ovarian cancer, according to a recent study led by OCRA grantee Duygu Ozmadenci, PhD, of the University of California, San Diego Moores Cancer Center. High-grade serous ovarian carcinoma (HGSOC) is the most common subtype of ovarian cancer, with approximately 75% of epithelial ovarian cancers … Continued
Audra Moran, President and CEO of OCRA, and Richard Pazdur, MD, Head of the Oncology Center of Excellence at FDA, shared reflections — both personal and professional — about ovarian cancer during a recent discussion. Topics that were covered include the critical role that patients play in research, drug regulation, and the policies that affect the … Continued
Dr. Benoît Brangantini, of Mayo Clinic, is a 2021 recipient of OCRA’s Mentored Investigator Grant. With his project, “Probing Homologous Recombination DNA Repair Factors in Chromatin by cryo-EM,” Dr. Bragantini aims to better understand how DNA damage and repair mechanisms can lead to ovarian cancer, and how these processes can be controlled to prevent ovarian … Continued
We need your help today to ensure that a critical ovarian cancer research program is adequately funded. The congressional appropriations process for the 2023 fiscal year is well underway and the ovarian cancer community is requesting $50 million for the Ovarian Cancer Research Program (OCRP) at Department of Defense (DoD), a $5 million increase over current funding levels. … Continued
Submitted by ovarian cancer survivor Annie Ellis, OCRA Research Advocate and Scientific Advisory Committee member This year’s SGO annual meeting was held in Phoenix, Arizona from March 18-21. Approximately 2,100 medical professionals attended in person with several hundred more attending virtually to learn the latest on gynecologic cancers. By now, you may have seen professional coverage … Continued
Some ovarian cancers are genetically linked to the gynecologic disorder known as endometriosis, according to recent findings from an international team of researchers. Endometriosis is a disease in which tissue that normally lines the inside of the uterus — the endometrium — grows outside the uterus. Though endometriosis is classified as a benign disorder, it … Continued
With spring finally upon us, we want to give a shout-out to a group of OCRA Heroes who welcomed the season by setting themselves into motion, both literally and figuratively, to raise awareness and funds for our shared cause. Movement was the main theme for all of these supporters, who helped keep the momentum going … Continued
There are so many ways to spring into action and knowledge around our shared mission. Read on to learn about promising research findings, how to make your voice heard, ways to receive and generate support, and more! Research Advocacy Patient Support & Programs Events Ways to Give
Though palliative care and hospice care are both used to improve a patient’s quality of life, there are key distinctions between the two — as well as many commonly held misconceptions about how they differ. Dr. Lori Spoozak recently led an in-depth discussion about the two modes of care during an online session held as part of … Continued
Get email updates about research news, action alerts, and ways to join the fight.
